These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37555490)

  • 1. Enhancing diversity of clinical trial populations in multiple sclerosis.
    Marrie RA; Chataway J; Bierer BE; Finlayson M; Martinez-Lapiscina EH; Panagoulias J; Sormani MP; Williams MJ; Amezcua L
    Mult Scler; 2023 Aug; 29(9):1174-1185. PubMed ID: 37555490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved.
    Williams MJ; Orlando C; Akisanya J; Amezcua L
    Neurol Clin; 2024 Feb; 42(1):295-317. PubMed ID: 37980120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the efficiency of clinical trials in multiple sclerosis.
    Marrie RA; Sormani MP; Apap Mangion S; Bovis F; Cheung WY; Cutter GR; Feys P; Hill MD; Koch MW; McCreary M; Mowry EM; Park JJ; Piehl F; Salter A; Chataway J
    Mult Scler; 2023 Aug; 29(9):1136-1148. PubMed ID: 37555492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review.
    Finlayson M; Al-Mashita L; Sandhu R
    Mult Scler; 2023 Aug; 29(9):1149-1157. PubMed ID: 37555491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review.
    Amezcua L; Rivera VM; Vazquez TC; Baezconde-Garbanati L; Langer-Gould A
    JAMA Neurol; 2021 Dec; 78(12):1515-1524. PubMed ID: 34605866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action.
    Bodicoat DH; Routen AC; Willis A; Ekezie W; Gillies C; Lawson C; Yates T; Zaccardi F; Davies MJ; Khunti K
    Trials; 2021 Dec; 22(1):880. PubMed ID: 34863265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
    Oyer RA; Hurley P; Boehmer L; Bruinooge SS; Levit K; Barrett N; Benson A; Bernick LA; Byatt L; Charlot M; Crews J; DeLeon K; Fashoyin-Aje L; Garrett-Mayer E; Gralow JR; Green S; Guerra CE; Hamroun L; Hardy CM; Hempstead B; Jeames S; Mann M; Matin K; McCaskill-Stevens W; Merrill J; Nowakowski GS; Patel MI; Pressman A; Ramirez AG; Segura J; Segarra-Vasquez B; Hanley Williams J; Williams JE; Winkfield KM; Yang ES; Zwicker V; Pierce LJ
    J Clin Oncol; 2022 Jul; 40(19):2163-2171. PubMed ID: 35588469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing involvement of people with multiple sclerosis in clinical trial design.
    Gray E; Amjad A; Robertson J; Beveridge J; Scott S; Peryer G; Braisher M; Pugh C; Peres S; Marrie RA; Sormani MP; Chataway J
    Mult Scler; 2023 Aug; 29(9):1162-1173. PubMed ID: 37555494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping two decades of multiple sclerosis rehabilitation trials: A systematic scoping review and call to action to advance the study of race and ethnicity in rehabilitation research.
    Fakolade A; Akbar N; Mehelay S; Phadke S; Tang M; Alqahtani A; Pullattayil AK; Busse M
    Mult Scler Relat Disord; 2023 Apr; 72():104606. PubMed ID: 36917889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
    Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
    Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
    Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J
    Health Technol Assess; 2019 Jun; 23(27):1-166. PubMed ID: 31217069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.
    Whitaker JN; McFarland HF; Rudge P; Reingold SC
    Mult Scler; 1995 Apr; 1(1):37-47. PubMed ID: 9345468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
    Noseworthy JH; Vandervoort MK; Hopkins M; Ebers GC
    Neurology; 1989 Jul; 39(7):977-81. PubMed ID: 2739925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort.
    Pimentel Maldonado DA; Eusebio JR; Amezcua L; Vasileiou ES; Mowry EM; Hemond CC; Umeton Pizzolato R; Berrios Morales I; Radu I; Ionete C; Fitzgerald KC
    Mult Scler Relat Disord; 2022 Feb; 58():103451. PubMed ID: 34953410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for observational studies of comorbidity in multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Fiest K; Reider N; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1446-1453. PubMed ID: 26865523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor.
    Versavel S; Subasinghe A; Johnson K; Golonski N; Muhlhausen J; Perry P; Sanchez R
    Contemp Clin Trials; 2023 Mar; 126():107092. PubMed ID: 36702295
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.